企業プロフィール
GRI Bio 株価・ニュース・カタリスト
- ティッカー:
- GRI
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
1.73 USD (+3.59%)
終値
最終更新: 2026年8月17日
3.56M USD
時価総額
株価変動の要因
As of Aug 17, 2026, GRI closed up 3.59% at $1.73. No new same-company headline was identified in the current news window.
企業概要
事業概要
BioRestorative or GRI is a historical small-cap biotech entry tied to biologics and regenerative or related platform work. Its story is best understood as an early-stage development attempt rather than a mature commercial franchise.
所在地とセクター分類
GRI is a U.S.-listed biotech entry with a small-cap development profile. It sits in biotechnology rather than medtech or services.
ビジネスモデルの特徴
The business depended on early scientific progress, platform credibility, and access to capital. Investors historically watched whether the company could focus its pipeline and keep programs alive.
バイオ業界での位置付け
GRI occupies the historical small-cap biotech bucket. It is the type of name where the market cared most about whether the science could survive the financing cycle.
今後のカタリスト
- GRI Bio's catalyst setup now looks most tied to cough/shortness of breath, Commission, and the rest of its current pipeline. What gives this more shape is "The growing body of Phase 2a clinical, translational and biomarker data continues to reinforce GRI-0621's differentiated therapeutic potential in idiopathic pulmonary fibrosis.... That setup makes the next update more important than the headline financials themselves. The partnership angle also matters here, especially around (6) the inability of the Company to identify, in-license or acquire additional technology.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。